Author: 23andMe

23andMe Launches Health Report on Alzheimer’s Disease

Alzheimer’s disease is the most common form of dementia in older people and is projected to become a major health burden as the population of the United States ages. Currently more than five million Americans are thought to have the disease, but by the year 2050 that number is estimated to reach 15 million. ...

Read more

DTC Genetic Tests and the Future of Regulation: Make Your Voices Heard

On March 8th, the FDA convened a two-day advisory panel meeting to discuss questions related to direct-to-consumer genetic tests. The questions focused on the benefits and risks of providing consumers with direct access to these tests, potential strategies for communication and education to mitigate any ...

Read more

23andMe Presents at FDA Advisory Panel Meeting on Direct-to-Consumer Genetic Tests

Editor's note: This post has been altered from the original. The slides from the presentation have been removed. 23andMe, like many others, believes that individuals have a right to access their own genetic information and that personal genetics will pave the way for significant advances in healthcare. ...

Read more

23andMe to Attend FDA Public Advisory Committee Meeting on Direct-to-Consumer Genetic Tests

Last summer, the Food and Drug Administration (FDA) indicated that it would be revising its regulatory guidelines pertaining to laboratory-developed tests (LDTs), and that direct-to-consumer genetic tests such as 23andMe's Personal Genome Service® would potentially fall under that category. 23andMe has ...

Read more

What DTC Genetic Testing Can—and Can’t—Tell You

This week, Mary Carmichael of Newsweek is exploring the world of direct-to-consumer (DTC) genetic testing and deciding whether or not she'd like to find out about her own DNA information. 23andMe was asked to contribute a short piece on what you can—and can't—learn from services such as ours.  We were more ...

Read more

GAO Studies Science Non-Scientifically

As we posted here on the Spittoon yesterday, the Subcommittee on Oversight and Investigations of the House of Representatives Committee on Energy and Commerce held a hearing on “Direct-To-Consumer Genetic Testing and the Consequences to the Public Health.” Central to this hearing was an investigation by ...

Read more

Update on Congressional Hearing on Direct-To-Consumer Genetic Testing

This morning the Subcommittee on Oversight and Investigations of the House of Representatives Committee on Energy and Commerce held a hearing on “Direct-To-Consumer Genetic Testing and the Consequences to the Public Health.”  PDFs of written testimony submitted for the record and a link to the webcast of the ...

Read more

Absence of Evidence Is Not Evidence of Absence: Understanding What Genetic Testing Can (And Can’t) Tell You

Earlier today science writer Ed Yong wrote about his experience with 23andMe over at his blog, Not Exactly Rocket Science.  In this piece, he said that his 23andMe results showed that if he procreated with another science writer named Mark Henderson (a joke, as both are male), their child would not have ...

Read more

Congressional Hearing on Direct-To-Consumer Genetic Testing

On Thursday, July 22, the Subcommittee on Oversight and Investigations of the House of Representatives Committee on Energy and Commerce will hold a hearing on "Direct-To-Consumer Genetic Testing and the Consequences to the Public Health." The hearing begins 9:30 a.m. EDT and will take place in Room 2123, ...

Read more

Consumer Genomics Policy Forum Sponsored by 23andMe

On Wednesday July 14, 23andMe and California State Senator Alex Padilla co-hosted a day-long policy forum entitled "Genomics and the Consumer: The Present and Future of Personalized Medicine." The approximately 150 people in attendance—lawyers, scientists, ethicists, business people, elected officials and ...

Read more

Return to top